Routine Opt-Out HIV Testing Strategies in a Female Jail Setting: A Prospective Controlled Trial
Ravi Kavasery, Duncan Smith-Rohrberg Maru, Joshua Cornman-Homonoff et al. · 2009
Read Routine Opt-Out HIV Testing Strategies in a Female Jail Setting: A Prospective Controlled Trial by Ravi Kavasery, Duncan Smith-Rohrberg Maru, Joshua Cornman-Homonoff et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0007648.txt.
Introduction
Ravi Kavasery and colleagues published a trial report in PLOS ONE in 2009 on HIV testing in a women's jail. Ten million Americans pass through jails each year, making them an important venue for finding undiagnosed infections. New CDC guidelines recommended routine opt-out testing: everyone is tested unless they decline. The team ran a prospective, controlled trial of that strategy among newly incarcerated women. They also examined the best timing for offering the test.
Routine opt-out testing in the jail setting caught infections that risk-based testing would miss. Timing mattered: when in the intake process testing happens changes participation. The results give jail health services a tested playbook. Short stays mean the chance to test may not come again. The study treats a correctional setting as the public health opportunity it plainly is.
Catalog record
| CREATOR | Ravi Kavasery, Duncan Smith-Rohrberg Maru, Joshua Cornman-Homonoff et al. |
|---|---|
| YEAR | 2009 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 36 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0007648
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Routine Opt-Out HIV Testing Strategies in a Female Jail Setting: A Prospective Controlled Trial Authors: Ravi Kavasery, Duncan Smith-Rohrberg Maru, Joshua Cornman-Homonoff, Laurie N. Sylla, David Smith, Frederick L. Altice Published: 2009, PLOS ONE DOI: 10.1371/journal.pone.0007648 ABSTRACT Ten million Americans enter jails annually. The objective was to evaluate new CDC guidelines for routine opt-out HIV testing and examine the optimal time to implement routine opt-out HIV testing among newly incarcerated jail detainees. This prospective, controlled trial of routine opt-out HIV testing was conducted among 323 newly incarcerated female inmates in Connecticut's only women's jail. 323 sequential entrants to the women's jail over a five week period in August and September 2007 were assigned to be offered routine opt-out HIV testing at one of three points after incarceration: immediate (same day, n = 108), early (next day, n = 108), or delayed (7 days, n = 107). The primary outcome was the proportion of women in each group consenting to testing. Routine opt-out HIV testing was significantly highest (73%) among the early testing group compared to 55% for immediate and 50% for 7 days post-entry groups. Other factors significantly (p = 0.01) associated with being HIV tested were younger age and low likelihood of early release from jail based on bond value or type of charge for which women were arrested. In this correctional facility, routine opt-out HIV testing in a jail setting was feasible, with highest rates of testing if performed the day after incarceration. Lower testing rates were seen with immediate testing, where there is a high prevalence of inability or unwillingness to test, and with delayed testing, where attrition from jail increases with each passing day. ClinicalTrials.gov NCT00624247 INTRODUCTION Over 2.3 million people, or one in every 100 American adults, are incarcerated and their initial interface with the correctional system is usually via jail. [1] , [2] The prevalence of HIV infection in the United States is several-fold greater in correctional settings than in the general population. [3] Jails and prisons thus serve as important sites for HIV testing and treatment. [4] , [5] , [6] , [7] The Centers for Disease Control and Prevention's (CDC) recent recommendation to implement routine opt-out HIV testing in all healthcare settings, including jails, has not been achieved due to logistical, financial and legal constraints. [8] Systematic solutions to logistical constraints within correctional settings, however, provides an important opportunity to advance our public health goals and expand access to HIV services for this vulnerable population. [9] , [10] , [11] Jails interact with a large number of individuals at risk for HIV infection and pose unique logistical and health-related constraints that impact HIV testing strategies. [12] Jails, compared to prisons, are characterized by higher rates of turnover, [13] shorter stays, a higher prevalence of acute intoxication and withdrawal, and a higher number of inmates presenting with uncontrolled mental illness, recent HIV risk behaviors [14] , [15] and suicidal behavior. [16] , [17] , [18] , [19] Suicide incidence is three-times greater in jails than in prisons, with nearly a quarter taking place within 48 hours of admission. [20] , [21] Given the high attrition rate in jails, a major logistical challenge to implementing routine opt-out HIV testing is selecting the optimal time to conduct testing. [22] Newly incarcerated inmates might be too intoxicated or psychologically distressed to reliably consent to or opt out of routine testing, and may be unprepared to consider and respond to the consequences of a preliminary positive HIV test result. [12] , [23] Likewise, the public health challenge with postponing HIV testing is that many individuals experience relatively short stays in jail and will be released before being tested. [24] , [25] Therefore, the objective of this study was to evaluate the optimal time to conduct routine opt-out HIV testing of newly incarcerated jail inmates in a manner that maximized the number of individuals capable of consenting and willing to be tested. METHODS The protocol for this trial and supporting CONSORT checklist are available as supporting information; see Checklist S1 and Protocol S1 . This study was approved by the Institutional Review Board at Yale University and by the Connecticut Department of Correction Research Committee. DESIGN OVERVIEW Over a 5-week period starting August 22, 2007, all 323 consecutive, newly incarcerated female inmates were offered routine opt-out HIV testing after being sequentially assigned to one of three study arms upon admission to the facility: 1) ‘immediate’ (during a mandatory initial medical screen the night of admission); 2) ‘early’ (during a required physical exam the following evening); or 3) ‘delayed’ (7 days after arrival to the facility). Decisions about timing for routine opt-out HIV testing were based upon previous surveys of correctional and medical professionals as well as from experts in the field of HIV testing in correctional settings. These three time points were chosen to coincide with other routine healthcare activities at the jail in order to simulate the future implementation of a routine opt-out HIV testing protocol. SETTING AND PARTICIPANTS This prospective, controlled trial was conducted at York Correctional Institution in Niantic, Connecticut, the state's sole correctional facility for women. Intake involves both sentenced and pre-trial detainees. The average daily census is 1641 inmates. Similar to other jails, a brief, standardized medical and psychiatric assessment is routinely conducted on all inmates, including medical, sexual, and drug-use histories immediately upon arrival. Testing for pregnancy, opioids, tuberculosis and acute medical conditions is routinely conducted. Inmates maintained on or experiencing opioid withdrawal symptoms are provided a methadone taper. The evening following admission, a routine physical examination, including Papanicolaou smear and phlebotomy, occurs in all new inmates remaining within the facility. [26] Voluntary HIV testing is available by medical referral or by self-request and often involves a waiting list. Inmates with self-reported HIV risks within the previous 90 days are deferred testing. Newly confirmed HIV positive test results are reported to the Connecticut Department of Public Health. As part of this study, all newly incarcerated inmates were sequentially approached for competency and HIV testing and sequentially assigned to one of the three study groups. Eligibility to be HIV tested required demonstration of competency by: 1) clinician-confirmed ability to demonstrate knowledge of the risks, benefits, and consequences of HIV testing in accordance with the MacArthur Competence Assessment Tool for Clinical Research [MacCAT-CR] [27] ; and 2) no self-reported suicidal ideation or evidence of mental instability. INTERVENTION For each testing group, the inmate was approached with the following scripted statement: “As part of your regular medical care, HIV testing can now be done using an oral swab that you swipe across your gums. You can receive your results after 20 minutes. Would you like to be tested at this time?” If the inmate responded affirmatively, she was instructed to self-administer the oral HIV test by the clinical staff in the ‘immediate’ and ‘early’ test groups as part of routine clinical activities in order to simulate how routine opt-out HIV testing would be performed if not embedded within a complicated research study. On day 7, research personnel oversaw the verbal consent and self-administration procedures using the same process. All subjects were instructed that HIV results require minimal waiting. Anyone not wanting to know HIV test